All SARS-CoV-2 articles – Page 3
-
NewsWomen are three times more likely than men to get severe long COVID: Here’s why
Researchers have identified a distinct immune signature in female long Covid patients versus male patients. They found evidence of ’gut leakiness’ in the women patients, including elevated blood levels of intestinal fatty acid binding protein, lipopolysaccharide, and the soluble protein CD14 — all signs of gut inflammation that can then trigger further systemic inflammation.
-
NewsHuman PARP gene could be novel target for viral diseases or immune-mediated disorders
Researchershave discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system. Their study could guide development of antiviral therapies for several groups of viral infection.
-
NewsCould tiny airborne plastics help viruses spread? Scientists warn of a hidden infection risk
While plastics are already recognized as a global environmental threat, a new commentary highlights that their microscopic airborne forms could also play a hidden role in human infection.
-
NewsNo-needle test can tell if flu/COVID vaccines are effective
A team of researchers has developed a skin patch that can detect antibodies associated with COVID and flu infections. It’s orders of magnitude more sensitive than existing tests, uses just a half volt of electricity, and can return results in 10 minutes.
-
NewsCOVID-19 vaccination lowers long COVID risk in adolescents
Adolescents who were vaccinated against COVID-19 were less likely to develop long COVID after their first SARS-CoV-2 infection than unvaccinated peers, finds a new study.
-
NewsERC Synergy Grant awarded to physicist Michael Lässig and virologist Florian Klein
Researchers have been awarded a Synergy Grant by the European Research Council (ERC) for the project CoEvolve, which investigates the co-evolution of viruses and the immune system.
-
NewsCOVID-19 vaccination linked to reduced infections in children with eczema
Children with atopic dermatitis (AD), commonly known as eczema, may experience fewer infections and allergic complications if they receive the COVID-19 vaccine, according to new research.
-
NewsResearch finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination
A whole-population study showed that although these conditions were rare, children and young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection than after having the vaccine — and the risks after infection lasted much longer.
-
NewsCOVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children
Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they turn 3 years old, including speech delays, autism, motor disorders, and other developmental delays, according to new research.
-
NewsSome acute and chronic viral infections may increase the risk of cardiovascular disease
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent research.
-
NewsNew 2025 data shows COVID-19 vaccines provide effective, durable protection
Updated COVID-19 vaccines are still providing effective protection against infection, emergency department visits, hospitalization and death, according to new research.
-
NewsStudy finds COVID-19 mRNA vaccine sparks immune response to fight cancer
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
-
NewsBreakthrough in coronavirus fight: scientists develop powerful bispecific inhibitor to combat a wide range of coronaviruses
Researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid.
-
NewsSafer, more effective vaccines with new mRNA vaccine technology
A new messenger ribonucleic acid (mRNA) vaccine technology could make future vaccines safer, more effective, and less burdensome for patients. The new approach uses albumin-recruiting lipid nanoparticles to deliver mRNA precisely to lymph nodes while bypassing the liver.
-
NewsWHO upgrades its public health intelligence system to boost global health security
The World Health Organization (WHO) has launched version 2.0 of the Epidemic Intelligence from Open Sources (EIOS) system, used globally for the early detection of public health threats.
-
NewsProtein nanorings designed to detect and neutralize SARS-CoV2 virus
Scientists have generated a new ring-shaped protein nanomaterial capable of strongly binding to and neutralising the SARS-CoV2 virus. The new nanomaterial is formed by a scaffold based on recombinant ring-like proteins (RLPs), to which mini proteins were incorporated.
-
NewsResearch team with the latest Nobel Prize laureate reveals regulatory immune cell precursors disrupted in severe COVID-19
A research team joined by Professor Shimon Sakaguchi – the latest Nobel Laureate in Physiology or Medicine – has identified a subset of immune cells called precursor T follicular regulatory cells (preTfr) that play a critical role in preventing autoantibody production.
-
NewsScientists blaze new path to fighting viral diseases
Scientists have identified a potential new drug against the virus that causes COVID-19 - and devised a powerful new platform for finding medicines to fight many types of infectious diseases. Compound 6, led SARS-CoV-2 viral proteins to misfold, malfunction, and ultimately, be destroyed and removed by cells, in lab tests.
-
NewsHeart rhythm disorder POTS common in patients with long COVID
A new study shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those affected are middle-aged women.
-
NewsPotential biomarker for the development of long COVID identified
A research team has demonstrated that a specific component of the immune system (PTX-3) remains at significantly higher levels in the blood of patients who have suffered from severe COVID-19, even months after the acute infection has subsided.